View AMCP comments to the CMS’s Draft CY 2026 Part D Redesign Program Instructions.
View AMCP comments to the CMS’s Advance Notice of Methodological Changes for Calendar Year (CY) 2026 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies
Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.
Academy of Managed Care Pharmacy (AMCP) issued the following statement from AMCP CEO Susan A. Cantrell, MHL, RPh, CAE, about President Trump’s potential executive order to cut thousands of jobs at the Department of Health and Human Services:
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) February 2025 Issue
The Academy of Managed Care Pharmacy (AMCP) thanks the Food and Drug Administration (FDA) for the opportunity to provide comments in response to the “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics” (Draft Guidance), issued on December 5, 2024.
